31 original articles preserved
Every published WordPress article is available with its original body, featured image, metadata, category assignments, internal links and URL.
1 Aug 2026
Retatrutide, Tirzepatide and Semaglutide compared: receptor targets, trial data, and research status of triple vs dual vs single agonists.
Read article →
1 Aug 2026
Retatrutide 10mg vials average US$94 worldwide, ranging US$72-140+ by region. See the real price breakdown and how to avoid an unverified vendor.
Read article →
1 Aug 2026
Peptide reseller gross margins average 12.0x cost across 20 verified retailers. See the real regional pricing data, net profit breakdown, and startup costs.
Read article →
30 July 2026
What separates a safe source from a risky one: third-party lab testing, verified manufacturing, and an authorized reseller network.
Read article →
14 July 2026
What’s next for peptide research? A forward-looking analysis of emerging peptide science, clinical translation, safety, and regulatory evolution.
Read article →
2 July 2026
Cagrilintide vs Tirzepatide: a research-driven comparison of how these weight-loss peptides work, dosing considerations, and what the evidence shows so far.
Read article →
25 June 2026
PT-141 vs Melanotan II: both act on the same receptor family but differ in risks, regulation, and research intent. Here is what the science shows.
Read article →
18 June 2026
Do peptides actually slow aging? A science-based breakdown of anti-aging peptide research, separating measurable outcomes from marketing hype.
Read article →
5 June 2026
What separates FDA-approved peptide drugs from research compounds? A clear, evidence-based look at regulation, safety, and clinical standards.
Read article →
28 May 2026
Why does peptide delivery method matter? Learn how injectable, oral, and intranasal peptides differ in bioavailability, stability, and research reliability.
Read article →
21 May 2026
Peptide research has advanced rapidly, but major gaps remain. What science still doesn't know about safety, dosing, and long-term risks.
Read article →
14 May 2026
What happens when peptides are used long term? This article explores receptor adaptation, desensitization, and safety data from extended research models.
Read article →
7 May 2026
Do peptides increase cancer risk? An evidence-based review of what research shows about cell growth signaling and oncogenic uncertainty.
Read article →
30 Apr 2026
AICAR activates AMPK, a master regulator of metabolism. Here's how it works, what studies show, and where the research limitations remain.
Read article →
22 Apr 2026
NAD+ is central to cellular energy, DNA repair, and aging research. How it functions, why levels decline with age, and what research shows.
Read article →
14 Apr 2026
Beyond the "bonding hormone" label: what research actually shows about oxytocin's role in stress, behavior, metabolism, and male health.
Read article →
6 Apr 2026
Hexarelin and Ipamorelin are both growth hormone-releasing peptides, but their potency, endocrine impact, and research risks differ significantly.
Read article →
26 Mar 2026
PEG-MGF is often called a powerful muscle-building peptide — but what does research actually support? Where the claims exceed the data.
Read article →
19 Mar 2026
A research-driven analysis of BPC-157 and muscle recovery—covering mechanisms, animal evidence, limitations, and common misconceptions.
Read article →
12 Mar 2026
CJC-1295 exists in two forms — DAC and no-DAC — with very different pharmacokinetics. Here's how they work and where misconceptions arise.
Read article →
5 Mar 2026
TB-500 and BPC-157 are often compared in tissue repair research, but they act through very different biological pathways. Here's how they differ.
Read article →
2 Mar 2026
A science-first comparison of growth hormone-releasing peptides: how CJC-1295, Ipamorelin, and Hexarelin differ in mechanism and risk.
Read article →
23 Feb 2026
What truly separates research-grade peptides from pharmaceutical-grade peptides? A clear, evidence-based breakdown of purity, regulation, safety, and use.
Read article →
16 Feb 2026
Does BPC-157 really promote tissue repair? This evidence-based analysis examines animal data, mechanisms, limitations, and what science actually supports.
Read article →
9 Feb 2026
A practical guide to interpreting peptide research—covering study models, dosage translation, methodology, and real-world limitations.
Read article →
2 Feb 2026
What does science actually say about peptides for muscle recovery and injury repair? A research-driven review of mechanisms, models, and limitations.
Read article →
26 Jan 2026
How do peptides differ from traditional drugs? An evidence-based comparison of mechanisms, safety profiles, and real-world research use.
Read article →
19 Jan 2026
An evidence-based guide to peptide compliance, ethics, and regulation — what responsible research means and where legal boundaries exist.
Read article →
12 Jan 2026
A clear, step-by-step explanation of how peptides move from lab research and animal models to human clinical trials—and why many never make it.
Read article →
5 Jan 2026
Are research peptides safe? This evidence-based analysis examines safety data, regulatory status, study limitations, and what current science actually supports.
Read article →
29 Dec 2025
A science-based introduction to peptides—what they are, how they work in the body, and why they play a growing role in modern biomedical research.
Read article →